lauantai 27. syyskuuta 2014

Quantity of Sugar in Food Supply Linked to Diabetes Rates

By Juliana Bunim on February 27, 2013
Does eating too much sugar cause diabetes?

For years, scientists have said “not exactly.”
Eating too much of any food, including sugar, can cause you to gain weight; it’s the resulting obesity that predisposes people to Type 2 diabetes, according to the prevailing theory.
But now the results of a large epidemiological study conducted at UC San Francisco suggest that sugar may also have a direct, independent link to diabetes.

Sanjay Basu, MD, PhD
Sanjay Basu, MD, PhD
Researchers examined data on global sugar availability and diabetes rates from 175 countries over the past decade. After accounting for obesity and a large array of other factors, the researchers found that increased sugar in a population’s food supply was linked to higher Type 2 diabetes rates, independent of obesity rates. Their study was published Feb. 27 in PLOS ONE.
The study provides the first large-scale, population-based evidence for the idea that not all calories are equal from a diabetes-risk standpoint.
“It was quite a surprise,” said Sanjay Basu, MD, PhD, an assistant professor of medicine at the Stanford Prevention Research Center and the study’s lead author. The research was conducted while Basu was a medical resident at UCSF and working with Robert Lustig, MD, a pediatric endocrinologist at UCSF Benioff Children’s Hospital and the paper’s senior author.
“We’re not diminishing the importance of obesity at all, but these data suggest that at a population level there are additional factors that contribute to diabetes risk besides obesity and total calorie intake, and that sugar appears to play a prominent role.”
Specifically, more sugar was correlated with more diabetes: For every additional 150 calories of sugar available per person per day, the prevalence of diabetes in the population rose 1 percent, even after controlling for obesity, physical activity, other types of calories and a number of economic and social variables. A 12-ounce can of soda contains about 150 calories of sugar. In contrast, an additional 150 calories of any type caused only a 0.1 percent increase in the population’s diabetes rate.

Population Exposure to Excess Sugar

Not only was sugar availability correlated to diabetes risk, but the longer a population was exposed to excess sugar, the higher its diabetes rate after controlling for obesity and other factors. In addition, diabetes rates dropped over time when sugar availability dropped, independent of changes to consumption of other calories and physical activity or obesity rates.
Robert Lustig, MD
Robert Lustig, MD
“Epidemiology cannot directly prove causation,” said Lustig. “But in medicine, we rely on the postulates of Sir Austin Bradford Hill to examine associations to infer causation, as we did with smoking. You expose the subject to an agent, you get a disease; you take the agent away, the disease gets better; you re-expose and the disease gets worse again. This study satisfies those criteria, and places sugar front and center.”

The findings do not prove that sugar causes diabetes, Basu emphasized, but do provide real-world support for the body of
previous laboratory and experimental trials that suggest sugar affects the liver and pancreas in ways that other types of foods or obesity do not. “We really put the data through a wringer in order to test it out,” Basu said.
The study used food-supply data from the United Nations Food and Agricultural Organization to estimate the availability of different foods in the 175 countries examined, as well as estimates from the International Diabetes Foundation on the prevalence of diabetes among 20- to 79-year-olds.
The researchers employed new statistical methods derived from econometrics to control for factors that could provide alternate explanations for an apparent link between sugar and diabetes, including overweight and obesity; many non-sugar components of the food supply, such as fiber, fruit, meat, cereals and oils; total calories available per day; sedentary behavior; rates of economic development; household income; urbanization of the population; tobacco and alcohol use; and percentage of the population age 65 or older, since age is also associated with diabetes risk.


Groundbreaking Study and Next Steps

“As far as I know, this is the first paper that has had data on the relationship of sugar consumption to diabetes,” said Marion Nestle, PhD, a professor of nutrition, food studies and public health at New York University who was not involved in the study. “This has been a source of controversy forever. It’s been very, very difficult to separate sugar from the calories it provides. This work is carefully done, it’s interesting and it deserves attention.
The fact that the paper used data obtained over time is an important strength, Basu said. “Point-in-time studies are susceptible to all kinds of reverse causality,” he said. “For instance, people who are already diabetic or obese might eat more sugars due to food cravings.”
The researchers had to rely on food-availability data for this study instead of consumption data because no large-scale international databases exist to measure food consumption directly. Basu said follow-up studies are needed to examine possible links between diabetes and specific sugar sources, such as high-fructose corn syrup or sucrose, and also to evaluate the influence of specific foods, such as soft drinks or processed foods.
Another important future step, he said, is to conduct randomized clinical trials that could affirm a cause-and-effect connection between sugar consumption and diabetes. Although it would be unethical to feed people large amounts of sugar to try to induce diabetes, scientists could put participants of a study on a low-sugar diet to see if it reduces diabetes risk.
Basu was cautious about possible policy implications of his work, stating that more evidence is needed before enacting widespread policies to lower sugar consumption.
However, Nestle pointed out that the findings add to many other studies that suggest people should cut back on their sugar intake.
“How much circumstantial evidence do you need before you take action?” she said.
“At this point we have enough circumstantial evidence to advise people to keep their sugar a lot lower than it normally is.”
_
http://www.ucsf.edu/news/2013/02/13591/quantity-sugar-food-supply-linked-diabetes-rates
______
 

Kenelle ksylitoli sopii? 


Ksylitoli sopii lähes kaikille - myös useimmille diabeetikoille. Ksylitolituotteita suositellaan erityisesti karieksen riskiryhmille ja sairauden, lääkkeiden tai ikääntymisen aiheuttamiin kuivan suun ongelmiin. Ksylitoli on todettu turvalliseksi makeutusaineeksi. Ksylitoli on polyoli, jota esiintyy pieninä määrinä monissa kasvikunnan tuotteissa. FAO:n ja WHO:n yhteiselin on todennut vuonna 1983, että ksylitolin kohtuullinen käyttö on turvallista.  

Miksi ksylitolia suositellaan pikkulasten äideille? 


Karies eli hampaiden reikiintyminen on tarttuva tauti. Kliiniset tutkimukset osoittavat, että pikkulasten äitien säännöllinen Xylitol  -täysksylitolipurukumin käyttö vähentää merkittävästi kariesta aiheuttavien mutans streptokokki -bakteerien tarttumista äidiltä lapselle. Sama koskee tietysti myös isää ja muita lapsen lähipiiriin kuuluvia, joten koko perheen kannattaa syödä ksylitolia. Jos kaksivuotiaalla lapsella ei ole ollenkaan mutans streptokokki -bakteeria suussa, säilyvät hänen hampaansa todennäköisemmin pitkään terveenä. Lapsilla, joiden äidit söivät ksylitolipurukumia lapsen ollessa alle kahden vuoden ikäinen, esiintyi vähemmän kariesta vielä 10-vuotiaana. 

Miksi ksylitolipurukumia ja -pastillia jaetaan kouluissa ja päiväkodeissa? 



Ksylitolin nauttiminen lounaan ja välipalan päätteeksi estää happohyökkäyksen syntymisen. Siksi ksylitolipastilli tai -purukumi on luonnollinen osa ateriaa jo monissa kouluissa ja päiväkodeissa.
Ksylitolipurukumin jakelu aterian päätteeksi on päivittäisen hampaiden harjaamisen lisäksi tärkeä osa lasten hampaiden hoitoa.
Hampaiden harjaaminen kahdesti päivässä ja sen lisäksi ksylitolipurukumien ja ksylitolipastillien säännöllinen käyttö aterioiden jälkeen ovat todistetusti hyödyllisiä keinoja hampaiden reikiintymisen ehkäisyssä.

Monet kunnat ovat valinneet ennalta ehkäisevän strategian suun terveydentilan kohentamiseksi. Kuntien tavoitteena on myös parantaa suun terveydentilaa entistä kustannustehokkaammalla tavalla.

_
http://graviola.fi/kauppa-uutuudet/xylitol/
_
https://www.facebook.com/xylitol.se



______
 
 

 
__

GREEN TEA: GOOD FOR A HEALTHY METABOLISM

Green tea has long been touted as an elixir of health, and now we can add another item to the long list of green tea’s many potential benefits.
Scientists have discovered that green tea just may be a smart sip for a diabetes-prevention and -management plan.

More green, less blood glucose

Using a research method called meta-analysis, the study authors combines 17 previously published clinical trials on green tea and blood sugar (glucose) metabolism. The studies included a mix of:
  • healthy, normal-weight adults,
  • overweight and obese adults,
  • people with type 2 diabetes, and
  • people with “borderline” type 2 diabetes (a condition sometimes called prediabetes, metabolic syndrome, or insulin resistance).
All of the studies met specific criteria to ensure high quality, including that:
  • participants drank green tea or took green tea extract for two or more weeks,
  • the study was a randomized, controlled human trial,
  • the outcomes included baseline fasting glucose or insulin levels,
  • other dietary supplements and black and oolong teas were not allowed,
  • the study used a concurrent control group—people taking no green tea (placebo) to serve as a comparison to the active-treatment group.
The 17 studies created a total sample of 1,133 adults, and from this large pool of information (data), the researchers determined that green tea significantly reduced fasting glucose and insulin levels, and lowered hemoglobin A1c values (HbA1c).
HbA1c is a measure of how much glucose is bound to your red blood cells. Compared with glucose levels, which give a snapshot in time of your glucose levels, HbA1c gives an assessment of long-term glucose control.

Putting green tea to work for you

This study has a lot of strengths, including that it only considered randomized controlled trials, and eliminated other
types of tea and dietary supplements that could have contributed to effects on glucose control.

There are few downsides to green tea, so if you’re looking for ways to boost your diabetes-prevention plan, regularly sipping this brew is a smart step.

And according to the study authors, previous research suggests green tea is most effective in those who already have metabolic syndrome, so take advantage if you are at risk.
Along with maintaining a healthy weight, exercising regularly, taking your medications as prescribed, and avoiding cigarettes:
  • Catch a catechin. Green tea nutrients called catechins contribute to the brew’s beneficial effects. In this study, catechin intake ranged from 208 to 1,207 mg per day. A cup of green tea has about 200 mg of catechins, so aim for at least one cup daily, and more if you can.
  • Go low and watch the clock. If green tea tastes bitter to you, brew at a temperature slightly less than boiling, and steep for two to four minutes. Higher temperatures and longer brew times make for a more bitter brew.
  • Squeeze it. After brewing, dip your teabag up and down in the cup, then squeeze the liquid out, to maximize the catechins in your cup.
  • Add citrus, avoid milk. Sip green tea with a squeeze of lemon to help your body best use the nutrients, and don’t add milk to your tea; it may block catechin absorption.
Suzanne Dixon, MPH, MS, RD, an author, speaker, and internationally recognized expert in chronic disease prevention, epidemiology, and nutrition, has taught medical, nursing, public health, and alternative medicine coursework.
She has delivered over 150 invited lectures to health professionals and consumers and is the creator of a nutrition website acclaimed by the 
New York Times and Time magazine. Suzanne received her training in epidemiology and nutrition at the University of Michigan, School of Public Health at Ann Arbor. 


_______________________________



 TeaShop

maanantai 22. syyskuuta 2014

Diabetes

Diabetes on joukko erilaisia sairauksia, joille on yhteistä se, että veren sokeripitoisuus kasvaa liian suureksi. Avaintekijänä on insuliinihormoni: sen erityksen loppuminen, määrän riittämättömyys tai vaikutuksen heikkeneminen eli insuliiniresistenssi. 

Diabeteksen kaksi päämuotoa ovat tyypin 1 (nuoruustyypin) diabetes ja tyypin 2 (aikuistyypin) diabetes.
Tyypin 1 diabetes
Tyypin 1 (nuoruustyypin) diabeetikoita on Suomessa noin 50.000.

Syy
Elintoiminnoille välttämätöntä insuliinia ei erity, sillä insuliinia tuottavat haiman saarekesolut ovat tuhoutuneet.

Oireet
Tavallisia oireita ovat lisääntynyt virtsaneritys, jano, laihtuminen ja väsymys. Ne kehittyvät yleensä nopeasti, päivien tai viikkojen kuluessa.

Hoito
Jatkuva, elinikäinen insuliinihoito (pistoksina tai pumpulla) on elämän edellytys. Verensokerin omaseuranta ja hiilihydraattien laskeminen on tärkeää, koska insuliiniannokset sovitetaan hiilihydraattimäärien mukaisiksi. Liikunta ja terveellinen syöminen auttavat hoitamaan veriesuonien terveyttä ja ehkäisevät siten lisäsairauksia.

Hoidon päämääränä on hyvä elämä. Tavoitteena on pitää veren sokeripitoisuus sopivana. Tällöin sekä lisäsairauksien että liian matalien verensokeritasojen vaara on mahdollisimman pieni.

Sairastumisikä
Yleensä alle 40-vuotiaana. Suomessa lasten diabetes on yleisempi kuin missään muualla maailmassa.

Ehkäisy
Ehkäisykeinoja ei vielä tunneta, mutta mahdollisuuksia tutkitaan jatkuvasti.

Periytyvyys
2–5 %, jos äidillä on tyypin 1 diabetes. 6–8 %, jos isällä on. Vastasairastuneista diabeetikkolapsista vain noin 10 prosentilla on lähisuvussaan joku diabetesta sairastava.

Ensiapu
Jos insuliinihoitoinen diabeetikko tulee yllättäen huonovointiseksi tai menettää tajuntansa, kyseessä on melko varmasti liian alhaisesta verensokerista johtuva hypoglykemia, insuliinisokki. Sokin ensiapuohjeet löydät täältä.

Tyypin 2 diabetes
Tyypin 2 (aikuistyypin) diabeetikoita on Suomessa tiedossa noin 250.000. Lisäksi noin 200.000 sairastaa diabetesta tietämättään.

Syy
Haima tuottaa insuliinia, mutta se vaikuttaa heikosti tai insuliinia ei ole tarpeeseen nähden riittävästi. Insuliinituotanto voi vuosien kuluessa ehtyä kokonaan.

Oireet
Usein oireeton, kehittyy hitaasti jopa vuosien kuluessa. Todetaan usein sattumalta tai valtimosairauden puhjettua. Oireita voivat olla esimerkiksi väsymys erityisesti aterioiden jälkeen, jalkasäryt, lihaskouristelut sekä uupumus, johon uni ei auta.

Toteaminen
Katso verensokerin raja-arvot täältä.

Hoito
Painonhallinta liikunnan ja oikean ruokavalion avulla.
Tarvittaessa myös lääkehoito. Verenpaineen ja veren rasvojen hoito sekä veren liiallisen hyytymisen esto ovat tärkeitä lisäsairauksien estämseksi ja hoitamiseksi.
http://www.diabetes.fi/files/308/Ruokavaliosuositus.pdf

 
Sairastumisikä
Yleensä yli 40-vuotiaana. Lisääntyy nopeasti kaikkialla maailmassa ja yhä nuoremmissa ikäryhmissä.

Ehkäisy
Liikunta, terveellinen ruoka, painonhallinta ja tupakoimattomuus.

Periytyvyys
Riski sairastua tyypin 2 diabetekseen on 40 %, jos toisella vanhemmista on tyypin 2 diabetes. Riski on 70 %, jos molemmilla vanhemmilla on.


Maailman diabetespäivän 2012 luentoja

Diabetestutkimussäätiö järjesti Maailman diabetespäivän luentotilaisuuden Helsingissä keskiviikkona 14.11.2012. Tilaisuudessa pidettyjen luentojen aineistoja on ohessa.




Miksi Suomessa sairastutaan
tyypin 1 diabetekseen useammin kuin missään muualla maailmassa,

professori Mikael Knip:


http://www.diabetestutkimus.fi/files/94/Mikael_Knip_14.11.2012.pdf
_
http://www.diabetes.fi/
__

Diabeteksessa veren sokeripitoisuus kasvaa liian suureksi.

Ravinnossa olevat hiilihydraatit hajoavat glukoosiksi (rypälesokeri) ja kulkeutuvat vereen. Normaalioloissa kun veren glukoosipitoisuus kasvaa, haima erittää insuliinia, joka auttaa siirtämään glukoosia soluihin ja alentamaan veren glukoosipitoisuutta.
Kun ihminen sairastaa diabetesta, glukoosia ei siirry verestä solujen käyttöön riittävästi sen vuoksi, ettei keho tuota tarpeeksi insuliinia tai insuliinin vaikutus on heikentynyt. Koholla oleva verensokeri voi pitkällä aikavälillä vahingoittaa monia kehon kudoksia, kuten silmiä, munuaisia, sydäntä ja verenkiertoa.

Diabeetikoiden hoidon vuotuiset kokonaiskustannukset ovat yli 11 prosenttia terveydenhuollon kokonaiskustannuksista. Diabeteksen aiheuttamista kustannuksista arviolta 90 prosenttia johtuu lisätautien hoidosta (Stakes)

Ennaltaehkäisy
Kakkostyypin diabeteksen torjumisen keinot ovat painon pitäminen normaalina ja terveellinen ruokavalio. Vihreiden lehtivihannesten syömisen on todettu vähentävän sairastumisriskiä merkittävästi.

_
http://fi.wikipedia.org/wiki/Diabetes
____

Soursop leaf and bark (Powder), cure diabetes by regulating blood sugar

Last Updated: Saturday, 08 February 2014 02:40
Published: Thursday, 21 February 2013 19:17
Written by Varien Moos

It is a plant that grows in tropical areas in Central America and South America, especially in the Amazon.
It is also known as soursop, Guanábano, Catuche, Catoche, Anona Mexico, Graviola, Anona India, Mole.
The fruit is very delicate dark green covered with soft spines. Is relatively large and very thin shell. Should be harvested before they mature.
The flesh is white, creamy, meaty, juicy and slightly acidic, measuring 20-30 cm long, can weigh 6,8 kg.

All plant parts are used in natural medicine, including bark, leaves, roots and fruits, but the part that contains the greatest concentration of active ingredient is the leaf, where the Annonaceae acetogenins, which have been widely studied from the 1940 that came into use as an insecticide, leading to surprise scientists for its broad power, without causing any harmful effects in animals and man, so they agreed to fund research where, each day discovering new properties, which, as a result of scientific zeal and vested interests, remained in custody for over 20 years. Globalization and parallel studies in Japan and China, they found the light, the wonders of this generous plant.

Soursop leaf and bark (Powder), cure diabetes by regulating blood sugar, which shows its high effectiveness in endocrine commitments: liver, kidney, thyroid, pancreas, ovary, prostate, intestines, muscle relaxant smooth (heart), gall bladder, appendix and fights lung cancer or Lewis, breast cancer and brain tumors, hypotensive, anti-spasmodic, vasodilator, eliminates dust mites that cause asthma and bronchial diseases.

The leaf tea cure liver problems, improves the function of the pancreas. It is effective to deworm children, malaria cure, indicated to raise the defenses in patients with chemotherapy and also for people with HIV (AIDS).
_

__________________

Various morphological parts of Annona muricata have been reported to be useful as effective remedies against diabetes, hypertension, headache, dizziness, constipation, catarrh, liver problems, neuralgia, rheumatism and arthritis pain (de Almeida, 1993).     http://graviola.fi/tutkimukset-syopa/diabetes/

____________________



Ketoasidoosi


Ketoasidoosi on ketoaineiden liikamäärästä veressä johtuva asidoosi.
Kyseessä on harvinainen ja vaarallinen elimistön poikkeustila. Esimerkiksi paastoamisen tai vähähiilihydraattisen ruokavalion johdosta elimistö siirtyy ketoosiin, jolloin ketoaineiden tuotanto käynnistyy.

Haiman
tuottama insuliini säätelee ketoaineiden tuotantoa, mutta jos haima on vaurioitunut esimerkiksi diabeteksen vuoksi eikä kykene tuottamaan insuliinia, voi seurauksena olla hallitsematon ketoosi, eli ketoasidoosi.
Insuliinin puute aiheuttaa sen, ettei elimistö kykene hyödyntämään veressä olevaa glukoosia vaan alkaa polttaa rasvoja. Se tuottaa myös ketoaineita kudosten energiantarpeeseen (ketoosi). Tästä seuraa elimistön happamoituminen: veren pH on laskenut alle 7,35:n. Asidoosi voidaan todeta verikaasuanalyysillä, ketoosi taas veren tai virtsan ketoainemittauksesta.

Tyypin I diabetekseen sairastuvilla lähes kolmanneksella on ketoasidoosi sairauden toteamishetkellä (lapsilla tyypin II diabetekseen sairastuvilla noin joka kymmenellä), mutta insuliinihoidon alettua tilanne normalisoituu. Myös huonossa hoitotasapainossa oleville diabeetikoille voi kehittyä ketoasidoosi.Tulehdustauti voi heikentää insuliinin tehoa ja näin aiheuttaa ketoosia diabeetikolle.
 - Happomyrkytykseen sairastuneista menehtyy kahdeksan prosenttia.
Ketoasidoosi hoidetaan sairaalahoidossa. Potilaalle voidaan antaa nestehoitoa, ja ketoasidoosi korjautuu yleensä insuliinilla. Ketoasidoosia vaikeammin diagnosoitava ja hoidettava tila on maitohappoasidoosi

Ketoaine on elimistössä rasvasta ja etanolista muodostuva pienimolekyylinen yhdiste.

Ketoaineita muodostuu maksassa ja munuaisissa erityisesti silloin, kun hiilihydraatteja on niukasti saatavilla (kts.ketoosi) ja elimistö joutuu valmistamaan tarvittavan glukoosin itse glukoneogeneesissä.
Elimistössä muodostuu kolmea eri ketoainetta: asetoasetaatti, betahydroksibutyraatti ja asetoni.

Normaalisti ketoaineita syntyy maksan ja munuaisten solujen mitokondrioissa solujen glukoneogeneesin sivutuotteena.
Kun solut tuottavat glukoosia, ne tuottavat tarvitsemansa energian hapettamalla rasvahappoja asetyylikoentsyymi-A:ksi. Asetyylikoentsyymi-A, joka ei hapetu normaalisti sitruunahappokierrossa glukoneogeneesin ollessa käynnissä, muuntuu ketogeneesissä asetoasetaatiksi ja edelleen betahydroksibutyraatiksi.

Ketoaineet kulkeutuvat verenkierron mukana maksasta ja munuisista muualle elimistöön, jossa asetoasetaatti ja betahydroksibutyraatti voidaan käyttää hyväksi. Aivojen gliasolut käyttävät niitä lipidien rakentamiseen. Niitä voidaan hyödyntää myös energiantuotannossa. Erityisesti sydän, lihakset ja aivot käyttävät ketoaineita energianlähteenään.

Asetonia muodostuu spontaanisti asetoasetaatista ja sitä esiintyy paljon vähemmän kuin kahta muuta ketoainetta. Elimistö ei voi hyödyntää asetonia, joten se poistuu kehosta virtsan ja uloshengityksen mukana. Tästä johtuu ketoosissa olevan henkilön hengityksen "makea" tuoksu. Samasta syystä ketoosin voimakkuutta voidaan mitata virtsasta.
More: http://fi.wikipedia.org/wiki/Ketoasidoosi
____________________________

DIABETES -TESTI   € 24,90, sis. ALV 14% 

____________________________

The Relationship Between Diabetes and Pancreatic Cancer

“It’s complicated.”  But why should pancreatic cancer be any less convoluted than other aspects of the pancreas?  The origin of the embryologic pancreas develops from TWO buds off of the foregut – that EACH “typically” moves and develops, eventually merging to form what we know as the pancreas.  This somewhat individualistic merging process alone produces many anatomic anomalies, as any experienced pancreatic cancer surgeon will tell you.  Also, separately, the function of the pancreas is complicated, divided roughly into exocrine (digestive juice producing) and endocrine (the hormone producing “islet”) areas.
More: http://pancreatica.org/relationship-diabetes-pancreatic-cancer/
_____
Published online 2013 August 14. doi: 10.3748/wjg.v19.i30.4861.
Is diabetes mellitus a risk factor for pancreatic cancer?  

The relationship between diabetes mellitus and the risk of pancreatic cancer has been a matter of study for a long period of time. The importance of this topic is due to two main causes: the possible use of recent onset diabetes as a marker of the disease and, in particular, as a specific marker of pancreatic cancer, and the selection of a population at risk for pancreatic cancer. Thus, we decided to make an in-depth study of this topic; thus, we carried out an extensive literature search in order to re-assess the current knowledge on this topic.
Even if diabetes is found a decade before the appearance of pancreatic cancer as reported in meta-analytic studies, we cannot select those patients already having non detectable pancreatic cancer, at least with the imaging and biological techniques available today. We believe that more studies are necessary in order to definitively identify diabetes mellitus as a risk factor for pancreatic cancer taking into consideration that approximately 10 years are needed to diagnose symptomatic pancreatic cancer. At present, the answer to the as to whether diabetes and pancreatic cancer comes first similar to the adage of the chicken and the egg is that diabetes is the egg. More: http://www.wjgnet.com/1007-9327/full/v19/i30/4861.htm

_____

Acidic Diet Increases Risk of Diabetes, Study Says


In an analysis of data from the E3N-EPIC cohort, French women with higher scores on a measure of dietary acidity had about a 70% greater risk of developing diabetes than those whose diets were more alkaline, Guy Fagherazzi, PhD, of Gustave Roussy Institute in Villejuif in France, and colleagues reported online in Diabetologia.

Some work has suggested that Western diets rich in animal products and other acidogenic foods may create an acid load that isn’t compensated for by intake of fruits and vegetables. This can lead to chronic metabolic acidosis, which may play a role in cardiometabolic abnormalities.
Tracking the effects of acidosis

Most importantly from a blood-sugar control perspective, increasing acidosis can reduce the ability of insulin to bind at appropriate receptors in the body, and reduce insulin sensitivity. With this in mind, the scientists decided to analyse whether increased acidosis caused by dietary acid loads increased the risk of type-2 diabetes.
More: http://dailyhealthpost.com/acidic-diet-increases-risk-of-diabetes-study-says/#ixzz3E5IbiOX6
 
_____

Diabetes and pancreatic cancer: chicken or egg?

Abstract

OBJECTIVES:

Although half of all patients with pancreatic cancer are diabetic at the time of diagnosis, it remains unclear whether the diabetes associated with pancreatic cancer is a cause or an effect of the malignancy.

METHODS:

Epidemiologic studies were reviewed, the geographic prevalence of diabetes and the incidence of pancreatic cancer were examined, and clinical and laboratory studies were reviewed.

RESULTS:

Long-standing diabetes increases the risk of pancreatic cancer by 40% to 100%, and recent-onset diabetes is associated with a 4- to 7-fold increase in risk, such that 1% to 2% of patients with recent-onset diabetes will develop pancreatic cancer within 3 years. Treatment of diabetes or morbid obesity decreases the risk of pancreatic cancer, and metformin therapy decreases the risk due to both its antidiabetic and antineoplastic effects. Recent-onset diabetes associated with pancreatic cancer likely represents secondary or type 3 diabetes. The discrimination of type 3 diabetes from the more prevalent type 2 diabetes may identify the high-risk subgroup of diabetic patients in whom potentially curable pancreatic cancer may be found.

CONCLUSIONS:

Type 2 and type 1 diabetes mellitus increase the risk of pancreatic cancer with a latency period of more than 5 years. Type 3 diabetes mellitus is an effect, and therefore a harbinger, of pancreatic cancer in at least 30% of patients.
_
http://www.ncbi.nlm.nih.gov/pubmed/21412116


____

Glucagon

     Glucagon has the opposite effect to insulinGlucagon has the opposite effect to insulin
The effects of glucagon are the opposite of the effects induced by insulin. The two hormones need to work in partnership with each other to keep blood glucose levels balanced.

What is glucagon?

Glucagon is a hormone that is produced by alpha cells in a part of the pancreas known as the islets of Langerhans.

The role of glucagon in the body

Glucagon plays an active role in allowing the body to regulate the utilisation of glucose and fats.
Glucagon is released in response to low blood glucose levels and to events whereby the body needs additional glucose, such as in response to vigorous exercise.
When glucagon is released it can perform the following tasks:
  • Stimulating the liver to break down glycogen to be released into the blood as glucose
  • Activating gluconeogenesis, the conversion of amino acids into glucose
  • Breaking down stored fat (triglycerides) into fatty acids for use as fuel by cells

Glucagon and blood glucose levels

Glucagon serves to keep blood glucose levels high enough for the body to function well.
When blood glucose levels are low, glucagon is released and signals the liver to release glucose into the blood.

Glucagon secretion in response to meals varies depending on what we eat:
  • In response to a carbohydrate based meal, glucagon levels in the blood fall to prevent blood glucose rising too high.
  • In response to a high protein meal, glucagon levels in the blood rise.

Glucagon in diabetes

In people with diabetes, glucagon’s presence can raise blood glucose levels too high.
The reason for this is either because not enough insulin is present or, as is the case in type 2 diabetes, the body is less able to respond to insulin.
In type 1 diabetes, high levels of circulating insulin can inhibit the release of glucagon in response to hypoglycemia.
_
http://www.diabetes.co.uk/body/glucagon.html

Graviola 500 mg, 100 Caps. Immune Support. Positive Mood State. KevätALE -10%.


Graviola -lehtijauhe 120 gr